This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 358: 1033–1041. Errata in Lancet (2001) 358: 1556 and Lancet (2002) 359: 2120
Turnbull F ; Blood Pressure Lowering Treatment Trialists' Collaboration (2003) Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362: 1527–1535
Dahlof B et al. (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359: 995–1003
Acknowledgements
The synopsis was written by Emma Campbell, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Johnston, S. Preventing cerebrovascular and cardiovascular events after stroke: eprosartan or nitrendipine?. Nat Rev Neurol 2, 24–25 (2006). https://doi.org/10.1038/ncpneuro0090
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0090